Publication:
Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development.

dc.contributor.authorFont-Díaz, Joan
dc.contributor.authorJiménez-Panizo, Alba
dc.contributor.authorCaelles, Carme
dc.contributor.authorVivanco, María dM
dc.contributor.authorPérez, Paloma
dc.contributor.authorAranda, Ana
dc.contributor.authorEstébanez-Perpiñá, Eva
dc.contributor.authorCastrillo, Antonio
dc.contributor.authorRicote, Mercedes
dc.contributor.authorValledor, Annabel F
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderUnión Europea. Comisión Europeaes_ES
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderFundación ProCNICes_ES
dc.date.accessioned2022-03-03T12:13:41Z
dc.date.available2022-03-03T12:13:41Z
dc.date.issued2021-08
dc.description.abstractNuclear receptors (NRs) are a superfamily of ligand-activated transcription factors that act as biological sensors and use a combination of mechanisms to modulate positively and negatively gene expression in a spatial and temporal manner. The highly orchestrated biological actions of several NRs influence the proliferation, differentiation, and apoptosis of many different cell types. Synthetic ligands for several NRs have been the focus of extensive drug discovery efforts for cancer intervention. This review summarizes the roles in tumour growth and metastasis of several relevant NR family members, namely androgen receptor (AR), estrogen receptor (ER), glucocorticoid receptor (GR), thyroid hormone receptor (TR), retinoic acid receptors (RARs), retinoid X receptors (RXRs), peroxisome proliferator-activated receptors (PPARs), and liver X receptors (LXRs). These studies are key to develop improved therapeutic agents based on novel modes of action with reduced side effects and overcoming resistance.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by grants from the Spanish Ministry of Economy and Competitivity (MINECO) to AFV and CC (SAF201789510R) , to AA (SAF201783289R) , to MV (SAF201784934R) , to PP (SAF201788046R) , to EE (BFU201786906R) , and to the NuRCaMeIn network (SAF201790604REDT) ; grants from the Spanish Ministry of Science, Innovation and Universities (MCNU) and Fondo Europeo de Desarrollo Regional (FEDER) to MR (RTI2018-095928-B100) and AC (PID2019104284RBI00/AEI/10.13039/501100011033) ; a grant from Instituto de Salud Carlos IIIto AA (CIBERONC CB/16/00228) ; grants from the Autonomous Community of Madrid to AA (B2017/BMD-3724) and MR (MOIRB2017/BMD3684) ; grants from Fundacio La Marato de TV3 to CC (20160530) , AFV (201605-31) and MR (20160532) ; a grant from the Government of the Autonomous Community of Basque Country, Department of Industry, Tourism and Trade to MV (Elkartek, KK-2018/00054) ; and a grant from La Caixa to EEP (CaixaImpulseCI0018) . JFD received a fellowship from the Spanish Ministry of Science, Innovation and Universities (FPI, PRE2018085579) . The CNIC is supported by the MCNU and the Pro CNIC Foundation and is a Severo Ochoa Centre of Excellence (SEV20150505) . CIC bioGUNE is a Severo Ochoa Centre of Excellence (SEV20160644) .es_ES
dc.format.page58-75es_ES
dc.format.volume73es_ES
dc.identifier.citationSemin Cancer Biol . 2021 Aug;73:58-75es_ES
dc.identifier.doi10.1016/j.semcancer.2020.12.007es_ES
dc.identifier.e-issn1096-3650es_ES
dc.identifier.issn1044-579Xes_ES
dc.identifier.journalSeminars in cancer biologyes_ES
dc.identifier.pubmedID33309851es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13719
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SEV20160644es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Señalización de los Receptores Nucleareses_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleNuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationde41517f-d151-4bb6-8cf3-44f28ec51849
relation.isAuthorOfPublication.latestForDiscoveryde41517f-d151-4bb6-8cf3-44f28ec51849

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nucl_2021.pdf
Size:
2.98 MB
Format:
Adobe Portable Document Format
Description: